Alto Ingredients Inc

Alto Ingredients Inc has a market capitalization of $361.11 million and a price-to-earnings ratio of 27.07, indicating a relatively high valuation compared to its earnings. The company's liquidity position is characterized by a current ratio of 2.64, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, which may pose a liquidity risk. In terms of profitability, the company's return on equity is 5.44%, and its return on assets is 3.43%, both of which are below the industry median for renewable fuels companies. The company's operating margin is 1.53%, and its net profit margin is 1.45%, indicating that it is generating modest profits relative to its revenue. The debt-to-equity ratio of 0.32 suggests a relatively conservative capital structure, with a moderate level of leverage. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to higher operational and market risks, particularly in the renewable fuels industry, which is subject to regulatory and market volatility. Looking ahead, the company is expected to see a modest increase in revenue, with a projected growth rate of 5.0% for the current fiscal year and 7.0% for the next fiscal year. This growth is supported by the company's free cash flow of $31.43 million, which provides flexibility for reinvestment or debt reduction. However, the company's capital expenditures are negative, indicating a reduction in investment in long-term assets, which may affect its long-term growth potential. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The risk assessment indicates that the company has a moderate level of debt relative to its equity, but its net cash position is negative, which could impact its ability to meet short-term obligations. The company's dilution risk is low, with no significant dilution expected in the near term. Recent events, including analyst estimates and recommendations, suggest a generally positive outlook for the company. The mean price target of $6.75, with a median of $6.75, indicates that analysts expect the stock to appreciate from its current price of $4.66. The mean recommendation of 2.00 (on a scale from 1 to 5) suggests a "buy" rating, with two analysts recommending a "buy" and none recommending a "strong buy" or "hold".